Chapter 37
Migration, Hepatitis B, and Hepatitis C
Manuel Carballo,
Rowan Cody,
Megan Kelly,
Angelos Hatzakis,
Manuel Carballo
International Centre for Migration, Health and Development, Geneva, Switzerland
Search for more papers by this authorRowan Cody
International Centre for Migration, Health and Development, Geneva, Switzerland
Search for more papers by this authorMegan Kelly
Tulane School of Public Health and Tropical Medicine, New Orleans, LA, USA
Search for more papers by this authorAngelos Hatzakis
Athens University Medical School, Athens, Greece
Search for more papers by this authorManuel Carballo,
Rowan Cody,
Megan Kelly,
Angelos Hatzakis,
Manuel Carballo
International Centre for Migration, Health and Development, Geneva, Switzerland
Search for more papers by this authorRowan Cody
International Centre for Migration, Health and Development, Geneva, Switzerland
Search for more papers by this authorMegan Kelly
Tulane School of Public Health and Tropical Medicine, New Orleans, LA, USA
Search for more papers by this authorAngelos Hatzakis
Athens University Medical School, Athens, Greece
Search for more papers by this authorBook Editor(s):Howard C. Thomas BSc, PhD, FRCP, FRCPath, FMedSci,
Anna S.F. Lok MD,
Stephen A. Locarnini MBBS, BSc(Hons), PhD, FRCPath,
Arie J. Zuckerman MD, DSc, FRCP, FRCPath, FMedSci,
Howard C. Thomas BSc, PhD, FRCP, FRCPath, FMedSci
Emeritus Professor of Hepatology, Department of Medicine, Imperial College London, London, UK
Search for more papers by this authorAnna S.F. Lok MD
Alice Lohrman Andrews Research Professor in Hepatology, Director of Clinical Hepatology, Professor of Internal Medicine, Associate Chair for Clinical Research, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
Search for more papers by this authorStephen A. Locarnini MBBS, BSc(Hons), PhD, FRCPath
Head, Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC, Australia
Search for more papers by this authorArie J. Zuckerman MD, DSc, FRCP, FRCPath, FMedSci
Emeritus Professor of Medical Microbiology, Formerly Principal and Dean, Royal Free Hospital School of Medicine
Search for more papers by this authorSummary
The prevalence of hepatitis B and C varies considerably between countries and even regions of the world. Some countries have far higher rates of HBV and HCV than others. Today at a time of accelerating migration, however, when people are moving in increasing numbers from high-prevalence to lower prevalence areas, migration is changing the global distribution and profile of HBV and HCV. In doing so, it is presenting new public health and clinical medicine challenges. Many of these challenges remain ill-defined and poorly responded to by health authorities and systems.
References
- Perz JF, Armstrong GL, Farrington LA, Hutin YJA, Bell BP. The contributions of hepatitis B virus and hepatitis C infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006 Oct; 45(4): 529–538.
- Centers for Disease Control and Prevention (CDC), Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines 2010. MMWR Rocomm Rep 2010 Dec; 59(RR-12): 1–110.
- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat 2004 Mar; 11(2): 97–107.
- CDC. Map 3-04: prevalence of chronic infection with hepatitis B virus, 2006. 2012 [cited 2013 Jan 28]. Available from: http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/hepatitis-b.htm
- Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates for age-specific HBsAg seroprevalence and endemicity. Vaccine 2012 Mar;9: 30(12): 2212–2219.
- Hollinger FB, Lerat H. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis 2004 Jan; 189(1): 3–6.
- Mahoney FJ. Update on diagnosis, management and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999 Apr; 12(2): 351–366.
- International Organisation for Migration (IOM). Facts and figures: global estimates and trends. 2012 [cited 2013 Jan 28]. Available from: http://www.iom.int/cms/en/sites/iom/home/about-migration/facts-figures-1.html
- Papademetriou DG. The “Earned Regularization” Option in Managing Illegal Migration More Effectively: A Comparative Perspective. Washington, DC: Migration Policy Institute, 2005.
- Salt J, Hogarth J. Migrant trafficking and human smuggling in Europe: a review of the evidence. In: F Laczko, D Thompson, editors. Migrant Trafficking and Human Smuggling in Europe: A Review of the Evidence with Case Studies from Hungary, Poland and Ukraine. Geneva: International Organization for Migration, 2000; pp. 11–164.
- Carballo M, Divino J, Zeric D. Migration and health in the European Union. Trop Med Intl Health 1998; 3(12): 936–944.
- Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 1999; 77(10): 801–807.
- De Jong J, Wesenbeek R. Migration and health in the Netherlands. In C Huismann, editor. Country Reports on Migration and Health in Europe. Bonn: Wissenschaftliches Institut der Ärzte Deutschlands, 1997.
- Carballo M. The Process of Social Insertion of Migrants, Refugees, and Asylum Seekers in the Context of Access to and Use of Health and Social Services: Synthesis and Recommendations. Geneva: ICMHD/Synthese Geneva Report, 2004.
-
Siriez J,
Vitoux C,
Holvoet L, et al.
Principales pathologies des enfants revenant de vacances dans leur pays d'origine.
Journal de Pédiatrie et de Puériculture
2008;
21(2):
67–77.
10.1016/j.jpp.2008.02.003 Google Scholar
- Carballo M, Cody R, O'Reilly E, Felici AP, Kelly M. Migration, hepatitis B and hepatitis C. Report prepared for the Summit Conference on Hepatitis B and C, Brussels, 2010.
- van de Rantala M, Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe: a review. Eurosurveillance, 2008: Web.
- World Health Organization (WHO). Department of Communicable Diseases surveillance and response: hepatitis B. 2002 [cited 2013 Jan 28]. Available from: http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf
- Merkinaite S, Lazarus JV, Gore C. Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Publ Health 2008; 16(3): 106–110.
- Marschall T. Does migration from high and intermediate endemic regions increase the prevalence of hepatitis B infection in Germany? Deutsche Medizinische Wochenschrift 2005; 130(48): 2753–2758.
- Ott JJ, Paltiel AM, Winkler V, Becher H. Chronic disease mortality associated with infections agents: a comparative cohort study of migrants from the Former Soviet Union in Israel and Germany. BMC Publ Health 2008; doi 10.1186/1471-2458-8-110
- HPSC. Viral hepatitis 2004 annual report: viral hepatitis 2004. 2004 [cited 2013 Jan 28]. Available from: http://www.ndsc.ie/hpsc/AZ/HepatitisHIVAIDSandSTIs/HepatitisA/SurveillanceReports/File,2662,en.pdf
- Marschall T, Kretzschmar M, Mangen MJ, et al. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol 2008; 20(12): 1214–1225.
- Aggarwal R. Preventing and treating hepatitis B infection. BMJ 2004; 329(7474): 1080–1086.
- Health Protection Agency. Hepatitis B. In: Migrant Health – A Baseline Report. London: Health Protection Agency, 2006; pp. 59–65.
- Hawkes N. New wave of immigration blamed for doubling of hepatitis B cases. The Times (UK): 21 Nov 2007.
- Mann AG, Trotter CL, Adekoyejo Balogun M, et al. Hepatitis C in ethnic minority populations in England. J Viral Hepat 2008; 15(6): 421–426.
- Doughty S. Sickly immigrants are adding £1bn to costs of the NHS' £130,000 cost of flying six Afghans home. Mail Online, 23 Jun 2003 [cited 2013 Jan 28]. Available from: http://www.dailymail.co.uk/health/article-185768/Sickly-immigrants-add-1bn-NHS-bill.html
-
Eziefula C,
Brown M.
The health of recent migrants from resource poor countries.
Medicine
2010;
38(1):
60–65.
10.1016/j.mpmed.2009.09.026 Google Scholar
- López-Vélez R. Prevalence of hepatitis B, C and D markers in Sub-Saharan African immigrants. J Clin Gastroenterol 1997; 650–652.
- Monge-Maillo B, Begona A, Pérez-Molina JA. Imported infectious diseases in mobile populations, Spain. Emerg Infect Dis 2009 Nov [cited 2013 Jan 28]. Available from: http://wwwnc.cdc.gov/eid/article/15/11/09-0718.htm
- Távora-Tavira L, Teodosio R, Seixas J, et al. Sexually transmitted infections in an African migrant population in Portugal: a base-line study. J Infect Develop Countries 2007; 1(3); 326–328.
- Hosseini A, Seyyed K, Majid A, Mehdi M. High prevalence of HBV, HCV and HIV infections in gypsy populations residing in Shahr-E-Kord. Iranian Med 2004; 7(1): 20–22.
- Palumbo E, Scotto G, Faleo G, et al. Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis. Brazilian J Infect Dis 2007; 11(3): 311–313.
- Majori S, Baldo V, Tommasi I, et al. Hepatitis A, B, and C infection in a community of Sub-Saharan immigrants living in Verona (Italy). J Trav Med 2008; 15(5): 323–327.
-
Siriez JY,
Vitoux C,
Holvoet L, et al.
Principales pathologies des enfants revenant de vacances dans leur pays d'origine.
Journal de Pédiatrie et de Puériculture
2008;
21(2):
67–77.
10.1016/j.jpp.2008.02.003 Google Scholar
- Denis F, Ranger-Rogez S, Alain S, et al. Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years. Eur J Epidemiol 2004; 19(10): 973–978.
- Roudot-Thoraval F, Pawlotsky JM, Deforges L, et al. Anti-HCV seroprevalence in pregnant women in France. Gut 1993; 34(2 Suppl): 55–56.
- Elefsiniotis IS, Glynou I, Zorou I, et al. Surveillance for hepatitis B virus infection in pregnant women in Greece shows high rates of chronic infection among immigrants and low vaccination induced protection rates: preliminary results of a single centre study. Eurosurveillance 2009 [cited 2013 Feb 10]. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19132
- Malarnitsi-Puchner A, Papacharitonos S, Sotos D, et al. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 1996; 12(3): 297–301.
- Knorr, Holger M, Schnitzler P. Prevalence of hepatitis B virus infection among women at reproductive age at a German university hospital. J Clin Virol 2008; 41(4): 422–424.
- Fabris P, Baldo V, Baldovin T, et al. Changing epidemiology of HCV and HBV infections in northern Italy. J Clin Gastroenterol 2008; 42(5): 527–532.
- Fisker N, Georgsen J, Stolborg T, et al. Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centres. J Med Virol 2002; 68(4): 500–504.
- Cowan SA. Denmark decides not to introduce hepatitis B into the childhood vaccination programme. Eurosurveillance 2005 [cited 2013 Feb 10]. Available from: http://www.eurosurveillance.org/viewarticle.aspx?articleid=2827
- Organista KC, Carrillo H, Avala G. HIV prevention with Mexican migrants: review, critique, and recommendations. J AIDS 2004; 1(37 Suppl 4): 227–239.
- Parrado EA, Flippen CA, McQuiston C. Use of commercial sex workers among Hispanic migrants in North Carolina: implications for the spread of HIV. Perspect Sex Reprod Health 2004; 36(4): 150–156.
- Paschane D, Fisher DG. Etiology of limited transmission diseases among drug users: does recent migration magnify the risk of sharing injection equipment? Soc Sci Med 2000; 50: 1091–1097.
- Freeman R, Williams ML, Sanders LA. Drug use, AIDS knowledge and HIV risk behaviours of Cuban, Mexican, and Puerto Rican–born drug injectors who are recent entrants into the United States. Subst Use Misuse 1999; 34: 1765–1793.
- TAMPEP. Sex Work in Europe: A Mapping of the Prostitution Scene in 25 European Countries. Amsterdam: European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers, 2009.
- Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Ed Behav 1988; 15(2): 175–183.
- Wu LK, Rao CY, Jiang ZR. Survey on occupational knowledge, attitude, behaviour and requirements for health education of rural migrant workers. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2009; 27(7): 447–448.
-
Tran TT.
Understanding cultural barriers in hepatitis B virus infection.
Cleve Clin J Med
2009;
76(3):
10–13.
10.3949/ccjm.76.s3.03 Google Scholar
-
Cooper CL,
Giordano C,
Mackie D,
Mills EJ.
Equitable access to HIV-HCV co-infection can be achieved despite barriers to health care provision.
Ther Clin Risk Manag
2010;
26(6):
207–212.
10.2147/TCRM.S9951 Google Scholar
-
Romero-Ortuño R.
Access to health care for illegal immigrants in the EU: should we be concerned?
Eur J Health Law
2004;
11:
245–272.
10.1163/1571809042388572 Google Scholar
- Mumtaz Z, Shah HA, Hamid S, et al. Factors predicting in-hospital mortality in patients with cirrhosis hospitalized with gastro-esophageal variceal haemorrhage. Ind J Gastroenterol 2006; 25(5): 240–243.
- Hansen AR, Krasnik A, Høg E. Access to health care for undocumented immigrants: rights and practice. Danish Medical Bulletin 2007; 54: 50–51.
- Hatzakis A, Wait S, Bruix J, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat 2011; 18(1): 1–16.
- Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26(49): 6266–6273.
- Norredam M, Mygind A, Krasnik A. Access to health care for asylum seekers in the European Union – a comparative study of country policies. Eur J Publ Health 2006; 16(3): 285–289.
- Vuorenkoski L. Finland: health system review. Health Sys Trans 2008; 10(4): 1–168.
- Strandberg-Larsen M, Nielson MB, Signild Vallgårda, Krasnik A, Vrangbæk K. Denmark: health system review. Health Sys Trans 2007; 9(6): 1–164.
- United Nations Development Program. The immunization of youths against hepatitis B in the Sliven Roma community in partnership with GlaxoSmithKline continues. Press release, Sofia, 13 Oct 2004.
